from PHYLLIS BIRORI in Kigali, Rwanda Rwanda Bureau KIGALI, (CAJ News) – RWANDA is to start manufacturing its own vaccines following a US$2 billion investment on a vaccine plant by Germany-headquartered Biopharmaceutical New Technologies (BioNTech). The facility in the East African country's capital, Kigali, is forecast to make Rwanda and the entire continent self-reliant through
Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move that could bolster the continent’s efforts to address historical dependence on imported vaccines and establish its own robust biotechnology sector.
Africa: A Breakthrough for the African Vaccine Manufacturing allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.